Muscle Stimulation Devices Market size is poised to experience steady growth over the forecast period 2021-2027. This growth can be linked with the increasing cases of chronic pain and muscle injuries worldwide, especially among older adults. Muscle pain is also becoming common among younger adults due to increased participation in sports and physical fitness activities. A large number of sports enthusiasts are adopting numerous muscle stimulation devices to aid in warm-ups and rehabilitation in case of an injury. Besides these factors, ongoing technological advances and product innovations will provide a significant growth momentum to the market.
Different types of muscle stimulation devices are used to stimulate injured muscles or manipulate underlying nerves to alleviate pain. In addition to reduced pain and increased comfort, these devices offer advantages including non-evasive electrotherapy, portability, and cost benefit. Muscle stimulators work by improving blood circulation to the affected area and speed up repair, enhancing strength by flexing and working weakened muscle tissue, and adapting muscle fibers to certain patterns of response. Growing adoption of these devices will bolster the industry outlook.
Transcutaneous electrical nerve stimulator (TENS) segment is expected to witness rapid acceptance through 2027. These devices are primarily used to manage or block pain signals to the brain. A TENS is highly effective for the treatment of pain in upper and lower limbs. Non-invasive electrotherapy modalities such as TENS are experiencing strong demand in the market led by growing occurrence of chronic pain, accidents, and muscle-related sports injuries. The launch of technologically advanced products, such as wearable stimulators, will augment the overall market growth in the future. In June 2021, NeuroMetrix, Inc. announced that its Quell TENS platform will be used in a clinical trial to determine whether transcutaneous electrical nerve stimulation is a feasible, effective, and acceptable method for pain relief in patients with NMOSD.
The pain management segment of muscle stimulation devices market is slated to observe notable growth over 2021-2027. Increased occurrence of chronic pain among people has fostered the use of wearables and devices that offer significant therapeutic benefits. The usage of muscle stimulators among physiotherapists to manage chronic pain patients is also increasing. A number of muscle stimulation devices for pain management are constantly entering the market. For example, CyMedica Orthopedics, Inc’s IntelliHab system, an app-connected muscle stimulator, received U.S. FDA clearance for the treatment of osteoarthritic knee pain in June 2021.
Europe is likely to emerge as one of the biggest markets for muscle stimulation devices in the next few years. The regional growth trends can be attributed to the presence of established medical device and medtech companies. The prevalence of chronic pain, muscle injuries, and other ailments in Europe has increased considerably over the years. The region is also home to a massive elderly population base which means that the adoption of muscle stimulators in homecare settings could rise. Additionally, government investments in healthcare and the acceptance of latest technologies among healthcare providers will create a favorable outlook for the regional manufacturers.
Worldwide, NeuroMetrix Inc, DJO Global Inc. (Colfax Corporation), Axiobionics, Omron Corporation, R.S. Medical Inc., and Zynex Inc. are some of the established players in the market. The market leaders are focusing on introducing advanced devices and solutions to offer increased comfort to muscle pain patients and improve their quality of life. In September 2020, for instance, NeuroMetrix Inc. had rolled out the Quell Watch App for Apple Watch users. Quell is a wearable TENS device for foot, knee, and leg pain.
Many companies are also adopting strategies such as mergers, acquisitions, and partnerships to fuel their growth and expansion goals. Citing an instance, in April 2021, DJO Global Inc. had acquired MedShape Inc., a leading provider of musculoskeletal trauma products. Besides MedShape, DJO has made four other acquisitions since November 2020, including LiteCure Laser Therapy, Trilliant Surgical, Mathys, and Stryker’s arthroplasty product lines.
Owing to the unprecedented COVID-19 situation, the demand for lifesaving medical devices has increased worldwide. Many COVID-19 patients have been experiencing physiological disabilities affecting cardiovascular, respiratory, nerve, and musculoskeletal function due to long-term ICU treatment. Paralysis of respiratory muscles and the skeletal system has also been observed in some patients. Consequently, rehabilitation of such patients is emerging as a major challenge globally. The demand for different muscle stimulation devices, such as respiratory muscle stimulators, is positively impacting the market outlook.
Numerous respiratory muscle stimulation products have gained regulatory acceptance in 2020. For example, in May, Liberate Medical’s VentFree Respiratory Muscle Stimulator had received the U.S. FDA Emergency Use Authorization to reduce the dependence of adult COVID-19 patients on mechanical ventilation. This in turn could help reduce the risk of hospital acquired infections in COVID patients and ensure availability of ventilators for other patients.
A large number of COVID-19 patients recovering globally and the demand for muscle stimulators in homecare settings will certainly fuel the market trends over 2021-2027.
Market, by product type, 2013-2024 (USD Million)
Market, by application, 2013-2024 (USD Million)
Market by end-use, 2013-2024 (USD Million)
The above information is provided for the following regions and countries: